Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Karen Pharma is a specialty pharmaceutical company based in Istanbul, Turkey, that focuses on providing access to orphan drugs and treatments for rare diseases. Established in 2015, the company serves as a strategic partner for international biotechnology firms, managing the regulatory, market access, and distribution processes within the Turkish and MENA markets. Karen Pharma specializes in high-unmet-need therapeutic areas, including oncology, hematology, and inherited metabolic disorders. By leveraging its local expertise and regulatory knowledge, the company ensures that innovative, life-saving therapies reach patients with limited treatment options.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Karen Pharma.